Biomarkers have become essential in the diagnosis and treatment of cancer, so it’s no surprise there is a race underway to uncover more of them. Cancer biomarkers—which include inherited or acquired ...

Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...

Omics framework of colorectal cancer liver metastasis. Genomic, epigenetic, transcriptomic, proteomic, metabolomic, and microbiomic analyses were performed on tissue from primary colorectal cancer ...

From CAR T-cell breakthroughs to multi-omics precision tools, cancer research is rapidly evolving toward biomarker-guided trial designs. These approaches aim to match patients with the therapies most ...

The Institute of Intelligent Medical Research (IIMR) of BGI Genomics, in collaboration with Sweden's Uppsala University, has published the largest multi-omics study of colorectal cancer (CRC) to date.

Predicting tumor recurrence at the molecular level emerges as a critical challenge, especially for patients with complex multi-omics profiles. Traditional prognostic models relying on single ...

On January 13th and 14th 2022, the Center for Translational Cancer Research organized the virtual third Indian Cancer Genome Atlas (ICGA) Conference 2022 “Biobanking to Omics – Collecting the Global ...

Studying the spatial organization of all the cells in the niche or neighborhood of a tumor is crucial to fully understand how cancers progress. Since proximity speaks to cellular activity, the spatial ...

The three-dimensional analysis of cell types and their locations by spatial transcriptomics provides key information of their interactions within tissues or organs. Based on this technology, ...